Market Overview:
The Global Pneumoconiosis Market is expected to grow at a CAGR of XX% from 2018 to 2030. The market growth is attributed to the increasing incidence of pneumoconiosis, rising awareness about the disease, and technological advancements in the field of diagnosis and treatment. The Global Pneumoconiosis Market can be segmented by type, application, and region. By type, the market can be divided into organic dusts and non-organic substances. By application, it can be classified into hospitals, clinics, and others. Geographically speaking, it is analyzed across North America (U.S., Canada), Latin America (Mexico), Europe (Germany), Asia Pacific (China Japan India) Middle East & Africa(South Africa).
Product Definition:
A respiratory disease caused by the inhalation of dust, most often in coal mines.
Global Pneumoconiosis Market Size Growth Rate by Cause: 2016 VS 2021 VS 2027:
Global pneumoconiosis market was estimated to be worth USD 1.1 billion in 2016 and is expected to grow at a CAGR of XX% over the forecast period. Increasing prevalence of diseases such as tuberculosis, coal workers’ pneumoconiosis, and silicosis are some high impact rendering drivers for this market growth during the forecast period 2016-2021.
Organic Dusts:
Organic dusts are naturally occurring particulate matter that is extracted from the earth. Organic dusts are categorized into two types, namely PM10 and PM2.5 which have a maximum concentration of 10 & 2.5 micro meter respectively. The major sources of organic dust include agriculture, mining, oil & gas extraction and manufacturing industries; whereas the major consumers include construction activities and automotive industry (as it contains lubricants).
Application Insights:
Based on application, the global pnuemonoiosis market is segmented into hospitals, clinics and others. Hospitals held the largest share of over 70% in 2021. This can be attributed to factors such as presence of a large number of patients with lung diseases at a time when incidence rate is highest globally. As per estimates by the WHO, around 1 in 5 deaths occur due to lung cancer which makes it one of the leading causes of death worldwide. Thus rising cases have led to high demand for treatment resulting in growth at hospital level only during peak seasons or months i.e.
The others segment includes dentists offices, optometry practices and veterinary clinics among others where diagnosis or testing involving lungs is performed for any reason including respiratory problems among animals such as dogs cats etc.
Regional Analysis:
Europe dominated the global market in terms of revenue share in 2018. The presence of regulatory bodies, such as the European Medicines Agency (EMA) and Centre for Disease Control & Prevention (CDC), which monitor and regulate exposure to dusts is one of the major factors contributing to its dominance. In addition, rising awareness among people about occupational hazards due to exposure to minerals has also positively influenced regional growth.
Asia Pacific is expected to witness lucrative growth over the forecast period owing with rapid industrialization coupled with government initiatives for controlling pnuemonia across various countries including India, China, Japan and Australia. For instance; As per a WHO publication on April 2017 titledâ€Global Health Data Exchangeâ€; there were 1 million new cases reported in 2016 from Australia out of which 0.5% were caused by pneumonias associated with mineral dusts at work or home-based activities and 0.3% by coal mine workers respectively).
Growth Factors:
- Increasing awareness about the health hazards of pneumoconiosis and its prevention among workers in high-risk industries.
- Growing demand for better diagnostic tools and treatments for pneumoconiosis.
- Rising incidence of pneumoconiosis in developing countries due to increasing industrialization and urbanization.
- Government initiatives to prevent and control pneumoconiosis through education, screening, and treatment programs.
- Technological advancements that improve diagnosis accuracy and treatment options for pneumoconiosis patients
Scope Of The Report
Report Attributes
Report Details
Report Title
Pneumoconiosis Market Research Report
By Type
Global Pneumoconiosis Market Size Growth Rate by Cause: 2016 VS 2021 VS 2027, Organic Dusts, Non-Organic Substances
By Application
Hospitals, Clinics, Others
By Companies
Novartis, Abbott, Eli Lilly, Sunpharma, Sanofi, Novo Nordisk, AstraZeneca
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
184
Number of Tables & Figures
129
Customization Available
Yes, the report can be customized as per your need.
Global Pneumoconiosis Market Report Segments:
The global Pneumoconiosis market is segmented on the basis of:
Types
Global Pneumoconiosis Market Size Growth Rate by Cause: 2016 VS 2021 VS 2027, Organic Dusts, Non-Organic Substances
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novartis
- Abbott
- Eli Lilly
- Sunpharma
- Sanofi
- Novo Nordisk
- AstraZeneca
Highlights of The Pneumoconiosis Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Global Pneumoconiosis Market Size Growth Rate by Cause: 2016 VS 2021 VS 2027
- Organic Dusts
- Non-Organic Substances
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pneumoconiosis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pneumoconiosis is a lung disease caused by the inhalation of coal dust. Coal dust can cause inflammation and scarring in the lungs, which can lead to respiratory problems and even death.
Some of the key players operating in the pneumoconiosis market are Novartis, Abbott, Eli Lilly, Sunpharma, Sanofi, Novo Nordisk, AstraZeneca.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pneumoconiosis Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pneumoconiosis Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pneumoconiosis Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pneumoconiosis Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pneumoconiosis Market Size & Forecast, 2018-2028
4.5.1 Pneumoconiosis Market Size and Y-o-Y Growth
4.5.2 Pneumoconiosis Market Absolute $ Opportunity
Chapter 5 Global Pneumoconiosis Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Pneumoconiosis Market Size Forecast by Type
5.2.1 Global Pneumoconiosis Market Size Growth Rate by Cause: 2016 VS 2021 VS 2027
5.2.2 Organic Dusts
5.2.3 Non-Organic Substances
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Pneumoconiosis Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Pneumoconiosis Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pneumoconiosis Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pneumoconiosis Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Pneumoconiosis Analysis and Forecast
9.1 Introduction
9.2 North America Pneumoconiosis Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Pneumoconiosis Market Size Forecast by Type
9.6.1 Global Pneumoconiosis Market Size Growth Rate by Cause: 2016 VS 2021 VS 2027
9.6.2 Organic Dusts
9.6.3 Non-Organic Substances
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Pneumoconiosis Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Pneumoconiosis Analysis and Forecast
10.1 Introduction
10.2 Europe Pneumoconiosis Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Pneumoconiosis Market Size Forecast by Type
10.6.1 Global Pneumoconiosis Market Size Growth Rate by Cause: 2016 VS 2021 VS 2027
10.6.2 Organic Dusts
10.6.3 Non-Organic Substances
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Pneumoconiosis Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Pneumoconiosis Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Pneumoconiosis Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Pneumoconiosis Market Size Forecast by Type
11.6.1 Global Pneumoconiosis Market Size Growth Rate by Cause: 2016 VS 2021 VS 2027
11.6.2 Organic Dusts
11.6.3 Non-Organic Substances
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Pneumoconiosis Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Pneumoconiosis Analysis and Forecast
12.1 Introduction
12.2 Latin America Pneumoconiosis Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Pneumoconiosis Market Size Forecast by Type
12.6.1 Global Pneumoconiosis Market Size Growth Rate by Cause: 2016 VS 2021 VS 2027
12.6.2 Organic Dusts
12.6.3 Non-Organic Substances
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Pneumoconiosis Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Pneumoconiosis Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Pneumoconiosis Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Pneumoconiosis Market Size Forecast by Type
13.6.1 Global Pneumoconiosis Market Size Growth Rate by Cause: 2016 VS 2021 VS 2027
13.6.2 Organic Dusts
13.6.3 Non-Organic Substances
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Pneumoconiosis Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pneumoconiosis Market: Competitive Dashboard
14.2 Global Pneumoconiosis Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Novartis
14.3.2 Abbott
14.3.3 Eli Lilly
14.3.4 Sunpharma
14.3.5 Sanofi
14.3.6 Novo Nordisk
14.3.7 AstraZeneca
